Semaglutide has emerged as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to release more insulin and suppressing glucagon https://henripnbn252328.angelinsblog.com/34799031/grasping-semaglutide-a-comprehensive-guide